C
AMED

Covestor’s Amedisys AMED Stock Holding History

Covestor’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-567
Closed -$56K – 2239
2025
Q2 		$56K Sell
567
-482
-46% -$45.6K 0.03% 847
2025
Q1 		$97K Buy
1,049
+12
+1% +$1.11K 0.06% 508
2024
Q4 		$94K Buy
1,037
+340
+49% +$31.2K 0.06% 565
2024
Q3 		$67K Sell
697
-83
-11% -$8.1K 0.04% 733
2024
Q2 		$72K Hold
780
– – 0.05% 688
2024
Q1 		$72K Buy
780
+447
+134% +$41.9K 0.05% 725
2023
Q4 		$32K Sell
333
-190
-36% -$17.7K 0.02% 1021
2023
Q3 		$49K Sell
523
-230
-31% -$21.3K 0.04% 778
2023
Q2 		$69K Buy
753
+81
+12% +$6.64K 0.05% 639
2023
Q1 		$49K Buy
672
+261
+64% +$22.6K 0.04% 713
2022
Q4 		$34K Buy
411
+143
+53% +$12.9K 0.03% 868
2022
Q3 		$26K Sell
268
-83
-24% -$9.9K 0.02% 927
2022
Q2 		$37K Buy
351
+28
+9% +$3.58K 0.03% 822
2022
Q1 		$56K Buy
323
+152
+89% +$22.7K 0.04% 767
2021
Q4 		$28K Buy
+171
New +$27.5K 0.04% 768

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Covestor's AMED Position: Q3 2025 in Review

Covestor sold out of Amedisys (AMED) in Q3 2025, closing a stake of 567 shares — an estimated $56K sold.

Covestor first reported a position in AMED in Q4 2021 and held it in 15 quarters. The position peaked at $97K in Q1 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Covestor reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Covestor sold 567 Amedisys shares in Q3 2025, an estimated $56K.
  • Covestor first reported a position in Amedisys in Q4 2021 and held it in 15 quarters.
  • Covestor's Amedisys position peaked at $97K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Covestor's 13F filing for Q3 2025, filed 30 Oct 2025.